Lorlatinib in advanced ROS1-positive non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 1–2 trial
Shaw, Alice T, Solomon, Benjamin J, Chiari, Rita, Riely, Gregory J, Besse, Benjamin, Soo, Ross A, Kao, Steven, Lin, Chia-Chi, Bauer, Todd M, Clancy, Jill S, Thurm, Holger, Martini, Jean-Francois, Peltz, Gerson, Abbattista, Antonello, Li, Sherry, Ou, Sai-Hong Ignatius
Published in The lancet oncology (01.12.2019)
Published in The lancet oncology (01.12.2019)
Get full text
Journal Article
Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: pooled analyses after long-term follow-up in KEYNOTE-012
Mehra, Ranee, Seiwert, Tanguy Y., Gupta, Shilpa, Weiss, Jared, Gluck, Iris, Eder, Joseph P., Burtness, Barbara, Tahara, Makoto, Keam, Bhumsuk, Kang, Hyunseok, Muro, Kei, Geva, Ravit, Chung, Hyun Cheol, Lin, Chia-Chi, Aurora-Garg, Deepti, Ray, Archana, Pathiraja, Kumudu, Cheng, Jonathan, Chow, Laura Q. M., Haddad, Robert
Published in British journal of cancer (17.07.2018)
Published in British journal of cancer (17.07.2018)
Get full text
Journal Article
Cabozantinib for radioiodine-refractory differentiated thyroid cancer (COSMIC-311): a randomised, double-blind, placebo-controlled, phase 3 trial
Brose, Marcia S, Robinson, Bruce, Sherman, Steven I, Krajewska, Jolanta, Lin, Chia-Chi, Vaisman, Fernanda, Hoff, Ana O, Hitre, Erika, Bowles, Daniel W, Hernando, Jorge, Faoro, Leonardo, Banerjee, Kamalika, Oliver, Jennifer W, Keam, Bhumsuk, Capdevila, Jaume
Published in The lancet oncology (01.08.2021)
Published in The lancet oncology (01.08.2021)
Get full text
Journal Article
Lorlatinib in patients with ALK-positive non-small-cell lung cancer: results from a global phase 2 study
Solomon, Benjamin J, Besse, Benjamin, Bauer, Todd M, Felip, Enriqueta, Soo, Ross A, Camidge, D Ross, Chiari, Rita, Bearz, Alessandra, Lin, Chia-Chi, Gadgeel, Shirish M, Riely, Gregory J, Tan, Eng Huat, Seto, Takashi, James, Leonard P, Clancy, Jill S, Abbattista, Antonello, Martini, Jean-François, Chen, Joseph, Peltz, Gerson, Thurm, Holger, Ou, Sai-Hong Ignatius, Shaw, Alice T
Published in The lancet oncology (01.12.2018)
Published in The lancet oncology (01.12.2018)
Get full text
Journal Article
Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with advanced, PD-L1-positive papillary or follicular thyroid cancer
Mehnert, Janice M, Varga, Andrea, Brose, Marcia S, Aggarwal, Rahul R, Lin, Chia-Chi, Prawira, Amy, de Braud, Filippo, Tamura, Kenji, Doi, Toshihiko, Piha-Paul, Sarina A, Gilbert, Jill, Saraf, Sanatan, Thanigaimani, Pradeep, Cheng, Jonathan D, Keam, Bhumsuk
Published in BMC cancer (04.03.2019)
Published in BMC cancer (04.03.2019)
Get full text
Journal Article
Cabozantinib for previously treated radioiodine‐refractory differentiated thyroid cancer: Updated results from the phase 3 COSMIC‐311 trial
Brose, Marcia S., Robinson, Bruce G., Sherman, Steven I., Jarzab, Barbara, Lin, Chia‐Chi, Vaisman, Fernanda, Hoff, Ana O., Hitre, Erika, Bowles, Daniel W., Sen, Suvajit, Oliver, Jennifer W., Banerjee, Kamalika, Keam, Bhumsuk, Capdevila, Jaume
Published in Cancer (15.12.2022)
Published in Cancer (15.12.2022)
Get full text
Journal Article
ALK Resistance Mutations and Efficacy of Lorlatinib in Advanced Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer
Shaw, Alice T, Solomon, Benjamin J, Besse, Benjamin, Bauer, Todd M, Lin, Chia-Chi, Soo, Ross A, Riely, Gregory J, Ou, Sai-Hong Ignatius, Clancy, Jill S, Li, Sherry, Abbattista, Antonello, Thurm, Holger, Satouchi, Miyako, Camidge, D Ross, Kao, Steven, Chiari, Rita, Gadgeel, Shirish M, Felip, Enriqueta, Martini, Jean-François
Published in Journal of clinical oncology (01.06.2019)
Published in Journal of clinical oncology (01.06.2019)
Get full text
Journal Article
Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial
Muro, Kei, Dr, Chung, Hyun Cheol, Prof, Shankaran, Veena, MD, Geva, Ravit, MD, Catenacci, Daniel, MD, Gupta, Shilpa, MD, Eder, Joseph Paul, MD, Golan, Talia, MD, Le, Dung T, MD, Burtness, Barbara, MD, McRee, Autumn J, MD, Lin, Chia-Chi, MD, Pathiraja, Kumudu, MA, Lunceford, Jared, PhD, Emancipator, Kenneth, MD, Juco, Jonathan, MD, Koshiji, Minori, MD, Bang, Yung-Jue, Prof
Published in The lancet oncology (01.06.2016)
Published in The lancet oncology (01.06.2016)
Get full text
Journal Article
Osimertinib in Pretreated T790M-Positive Advanced Non-Small-Cell Lung Cancer: AURA Study Phase II Extension Component
Yang, James Chih-Hsin, Ahn, Myung-Ju, Kim, Dong-Wan, Ramalingam, Suresh S, Sequist, Lecia V, Su, Wu-Chou, Kim, Sang-We, Kim, Joo-Hang, Planchard, David, Felip, Enriqueta, Blackhall, Fiona, Haggstrom, Daniel, Yoh, Kiyotaka, Novello, Silvia, Gold, Kathryn, Hirashima, Tomonori, Lin, Chia-Chi, Mann, Helen, Cantarini, Mireille, Ghiorghiu, Serban, Jänne, Pasi A
Published in Journal of clinical oncology (20.04.2017)
Published in Journal of clinical oncology (20.04.2017)
Get full text
Journal Article
Pembrolizumab in Asia‐Pacific patients with advanced head and neck squamous cell carcinoma: Analyses from KEYNOTE‐012
Tahara, Makoto, Muro, Kei, Hasegawa, Yasuhisa, Chung, Hyun Cheol, Lin, Chia‐Chi, Keam, Bhumsuk, Takahashi, Kenichi, Cheng, Jonathan D., Bang, Yung‐Jue
Published in Cancer science (01.03.2018)
Published in Cancer science (01.03.2018)
Get full text
Journal Article
PD-1 Blockade in Anaplastic Thyroid Carcinoma
Capdevila, Jaume, Wirth, Lori J, Ernst, Thomas, Ponce Aix, Santiago, Lin, Chia-Chi, Ramlau, Rodryg, Butler, Marcus O, Delord, Jean-Pierre, Gelderblom, Hans, Ascierto, Paolo A, Fasolo, Angelica, Führer, Dagmar, Hütter-Krönke, Marie Luise, Forde, Patrick M, Wrona, Anna, Santoro, Armando, Sadow, Peter M, Szpakowski, Sebastian, Wu, Hongqian, Bostel, Geraldine, Faris, Jason, Cameron, Scott, Varga, Andreea, Taylor, Matthew
Published in Journal of clinical oncology (10.08.2020)
Published in Journal of clinical oncology (10.08.2020)
Get full text
Journal Article
Phase 1 study of capmatinib in MET‐positive solid tumor patients: Dose escalation and expansion of selected cohorts
Bang, Yung‐Jue, Su, Wu‐Chou, Schuler, Martin, Nam, Do‐Hyun, Lim, Wan Teck, Bauer, Todd M., Azaro, Analia, Poon, Ronnie Tung Ping, Hong, David, Lin, Chia‐Chi, Akimov, Mikhail, Ghebremariam, Samson, Zhao, Sylvia, Giovannini, Monica, Ma, Brigette
Published in Cancer science (01.02.2020)
Published in Cancer science (01.02.2020)
Get full text
Journal Article
Exposure‐Response Relationships in Patients With HER2‐Positive Metastatic Breast Cancer and Other Solid Tumors Treated With Trastuzumab Deruxtecan
Yin, Ophelia, Iwata, Hiroji, Lin, Chia‐Chi, Tamura, Kenji, Watanabe, Junichiro, Wada, Russ, Kastrissios, Helen, AbuTarif, Malaz, Garimella, Tushar, Lee, Caleb, Zhang, Lin, Shahidi, Javad, LaCreta, Frank
Published in Clinical pharmacology and therapeutics (01.10.2021)
Published in Clinical pharmacology and therapeutics (01.10.2021)
Get full text
Journal Article
Heteroalkyl‐Substitution in Molecular Organic Semiconductors: Chalcogen Effect on Crystallography, Conformational Lock, and Charge Transport
Afraj, Shakil N., Lin, Chia‐Chi, Velusamy, Arulmozhi, Cho, Chang‐Hui, Liu, Hsin‐Yi, Chen, Jianhua, Lee, Gene‐Hsiang, Fu, Jui‐Chen, Ni, Jen‐Shyang, Tung, Shih‐Huang, Yau, Shuehlin, Liu, Cheng‐Liang, Chen, Ming‐Chou, Facchetti, Antonio
Published in Advanced functional materials (01.07.2022)
Published in Advanced functional materials (01.07.2022)
Get full text
Journal Article
An Open‐Label, Multicenter, Phase I, Dose Escalation Study with Phase II Expansion Cohort to Determine the Safety, Pharmacokinetics, and Preliminary Antitumor Activity of Intravenous TKM‐080301 in Subjects with Advanced Hepatocellular Carcinoma
El Dika, Imane, Lim, Ho Yeong, Yong, Wei Peng, Lin, Chia‐Chi, Yoon, Jung‐Hwan, Modiano, Manuel, Freilich, Bradley, Choi, Hye Jin, Chao, Tsu‐Yi, Kelley, Robin K., Brown, Joanne, Knox, Jennifer, Ryoo, Baek‐Yeol, Yau, Thomas, Abou‐Alfa, Ghassan K.
Published in The oncologist (Dayton, Ohio) (01.06.2019)
Published in The oncologist (Dayton, Ohio) (01.06.2019)
Get full text
Journal Article
Efficacy and safety of pembrolizumab monotherapy in patients with advanced thyroid cancer in the phase 2 KEYNOTE‐158 study
Oh, Do‐Youn, Algazi, Alain, Capdevila, Jaume, Longo, Federico, Miller, Wilson, Chun Bing, Jerry Tan, Bonilla, Carlos Eduardo, Chung, Hyun Cheol, Guren, Tormod K., Lin, Chia‐Chi, Motola‐Kuba, Daniel, Shah, Manisha, Hadoux, Julien, Yao, Lili, Jin, Fan, Norwood, Kevin, Lebellec, Loïc
Published in Cancer (15.04.2023)
Published in Cancer (15.04.2023)
Get full text
Journal Article
Cabozantinib in Patients With Advanced Prostate Cancer: Results of a Phase II Randomized Discontinuation Trial
SMITH, David C, SMITH, Matthew R, VAISHAMPAYAN, Ulka N, HAAS, Naomi B, SPIRA, Alexander I, LARA, Primo N, LIN, Chia-Chi, SRINIVAS, Sandy, SELLA, Avishay, SCHÖFFSKI, Patrick, SCHEFFOLD, Christian, WEITZMAN, Aaron L, SWEENEY, Christopher, HUSSAIN, Maha, ELFIKY, Aymen A, LOGOTHETIS, Christopher, CORN, Paul G, VOGELZANG, Nicholas J, SMALL, Eric J, HARZSTARK, Andrea L, GORDON, Michael S
Published in Journal of clinical oncology (01.02.2013)
Published in Journal of clinical oncology (01.02.2013)
Get full text
Journal Article